Inogen, Inc. (INGN)
USD 6.84
(-2.98%)
USD 6.84
(-2.98%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 326.19 Million USD | -19.47% |
| 2022 | 405.04 Million USD | -17.26% |
| 2021 | 489.51 Million USD | 5.99% |
| 2020 | 461.85 Million USD | 3.24% |
| 2019 | 447.33 Million USD | 19.01% |
| 2018 | 375.89 Million USD | 36.65% |
| 2017 | 275.07 Million USD | 28.51% |
| 2016 | 214.04 Million USD | 32.69% |
| 2015 | 161.31 Million USD | 15.15% |
| 2014 | 140.08 Million USD | 70.01% |
| 2013 | 82.39 Million USD | 73.15% |
| 2012 | 47.58 Million USD | 97.2% |
| 2011 | 24.13 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 308.91 Million USD | -2.12% |
| 2024 Q1 | 315.59 Million USD | -3.25% |
| 2023 FY | 326.19 Million USD | -19.47% |
| 2023 Q1 | 385.67 Million USD | -4.78% |
| 2023 Q2 | 374.35 Million USD | -2.94% |
| 2023 Q3 | 343.69 Million USD | -8.19% |
| 2023 Q4 | 326.19 Million USD | -5.09% |
| 2022 Q2 | 470.06 Million USD | -0.96% |
| 2022 Q3 | 469.58 Million USD | -0.1% |
| 2022 Q4 | 405.04 Million USD | -13.74% |
| 2022 FY | 405.04 Million USD | -17.26% |
| 2022 Q1 | 474.61 Million USD | -3.04% |
| 2021 Q1 | 476.47 Million USD | 3.17% |
| 2021 FY | 489.51 Million USD | 5.99% |
| 2021 Q4 | 489.51 Million USD | -4.55% |
| 2021 Q3 | 512.85 Million USD | 2.95% |
| 2021 Q2 | 498.17 Million USD | 4.55% |
| 2020 Q1 | 459.12 Million USD | 2.63% |
| 2020 FY | 461.85 Million USD | 3.24% |
| 2020 Q4 | 461.85 Million USD | 0.33% |
| 2020 Q3 | 460.33 Million USD | 0.48% |
| 2020 Q2 | 458.12 Million USD | -0.22% |
| 2019 Q1 | 388.19 Million USD | 3.27% |
| 2019 FY | 447.33 Million USD | 19.01% |
| 2019 Q4 | 447.33 Million USD | 0.59% |
| 2019 Q3 | 444.73 Million USD | 10.14% |
| 2019 Q2 | 403.77 Million USD | 4.01% |
| 2018 Q3 | 357.11 Million USD | 7.36% |
| 2018 Q4 | 375.89 Million USD | 5.26% |
| 2018 FY | 375.89 Million USD | 36.65% |
| 2018 Q1 | 299.88 Million USD | 9.02% |
| 2018 Q2 | 332.63 Million USD | 10.92% |
| 2017 Q4 | 275.07 Million USD | 1.94% |
| 2017 Q2 | 251.23 Million USD | 10.37% |
| 2017 Q1 | 227.62 Million USD | 6.34% |
| 2017 Q3 | 269.84 Million USD | 7.41% |
| 2017 FY | 275.07 Million USD | 28.51% |
| 2016 Q2 | 182.78 Million USD | 8.54% |
| 2016 FY | 214.04 Million USD | 32.69% |
| 2016 Q1 | 168.4 Million USD | 4.39% |
| 2016 Q4 | 214.04 Million USD | 9.89% |
| 2016 Q3 | 194.79 Million USD | 6.57% |
| 2015 Q1 | 148.46 Million USD | 5.98% |
| 2015 FY | 161.31 Million USD | 15.15% |
| 2015 Q4 | 161.31 Million USD | 2.44% |
| 2015 Q3 | 157.47 Million USD | 0.17% |
| 2015 Q2 | 157.19 Million USD | 5.89% |
| 2014 Q2 | 145.46 Million USD | 7.35% |
| 2014 Q1 | 135.5 Million USD | 64.46% |
| 2014 FY | 140.08 Million USD | 70.01% |
| 2014 Q4 | 140.08 Million USD | 2.14% |
| 2014 Q3 | 137.15 Million USD | -5.71% |
| 2013 Q2 | 55.74 Million USD | 0.0% |
| 2013 Q3 | 60.86 Million USD | 9.18% |
| 2013 FY | 82.39 Million USD | 73.15% |
| 2013 Q1 | - USD | -100.0% |
| 2013 Q4 | 82.39 Million USD | 35.38% |
| 2012 FY | 47.58 Million USD | 97.2% |
| 2012 Q4 | 47.58 Million USD | 0.0% |
| 2011 FY | 24.13 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 31.36 Million USD | -939.96% |
| BrainsWay Ltd. | 62.97 Million USD | -417.998% |
| Cerus Corporation | 197.74 Million USD | -64.954% |
| Envoy Medical, Inc. | 7.64 Million USD | -4169.555% |
| electroCore, Inc. | 16.38 Million USD | -1890.566% |
| Helius Medical Technologies, Inc. | 7.69 Million USD | -4140.692% |
| IceCure Medical Ltd | 16.41 Million USD | -1887.776% |
| OrthoPediatrics Corp. | 449.58 Million USD | 27.446% |
| Lucid Diagnostics Inc. | 27.27 Million USD | -1096.164% |
| Monogram Orthopaedics, Inc. | 16.57 Million USD | -1867.512% |
| MaxCyte, Inc. | 268.27 Million USD | -21.59% |
| NeuroOne Medical Technologies Corporation | 8.09 Million USD | -3928.422% |
| Nexalin Technology, Inc. | 3.63 Million USD | -8881.32% |
| Orthofix Medical Inc. | 925.31 Million USD | 64.748% |
| PAVmed Inc | 33.11 Million USD | -884.915% |
| Rapid Micro Biosystems, Inc. | 143.45 Million USD | -127.389% |
| RxSight, Inc. | 182.55 Million USD | -78.687% |
| Sight Sciences, Inc. | 166.65 Million USD | -95.735% |
| SI-BONE, Inc. | 230.42 Million USD | -41.562% |
| TELA Bio, Inc. | 78.04 Million USD | -317.94% |
| Treace Medical Concepts, Inc. | 251.9 Million USD | -29.49% |
| Vivos Therapeutics, Inc. | 10.73 Million USD | -2940.019% |
| Acutus Medical, Inc. | 53.96 Million USD | -504.511% |
| Talis Biomedical Corporation | 98.34 Million USD | -231.7% |
| Spectral AI, Inc. | 10.69 Million USD | -2950.823% |
| Nano-X Imaging Ltd. | 218.64 Million USD | -49.187% |
| CVRx, Inc. | 115.22 Million USD | -183.083% |
| DIH Holding US, Inc. Warrants | 58.66 Million USD | -456.066% |
| PetVivo Holdings, Inc. | 3.11 Million USD | -10370.867% |
| Bioventus Inc. | 810.91 Million USD | 59.774% |
| Venus Concept Inc. | 93.65 Million USD | -248.297% |
| TriSalus Life Sciences, Inc. | 25.72 Million USD | -1168.004% |
| LivaNova PLC | 2.42 Billion USD | 86.574% |
| 908 Devices Inc. | 202.98 Million USD | -60.702% |
| Alphatec Holdings, Inc. | 805.2 Million USD | 59.489% |
| Nemaura Medical Inc. | 14.56 Million USD | -2139.846% |
| NeuroPace, Inc. | 107.65 Million USD | -203.011% |
| LENSAR, Inc. | 69.58 Million USD | -368.771% |
| Apyx Medical Corporation | 79.24 Million USD | -311.653% |
| Cutera, Inc. | 346.29 Million USD | 5.804% |
| STRATA Skin Sciences, Inc. | 42.01 Million USD | -676.357% |
| BioSig Technologies, Inc. | 1.79 Million USD | -18042.047% |
| Anika Therapeutics, Inc. | 270.63 Million USD | -20.53% |
| ClearPoint Neuro, Inc. | 42.66 Million USD | -664.619% |
| Integra LifeSciences Holdings Corporation | 3.78 Billion USD | 91.375% |
| Axonics, Inc. | 719.92 Million USD | 54.69% |
| Outset Medical, Inc. | 313.8 Million USD | -3.949% |
| IRIDEX Corporation | 34.43 Million USD | -847.247% |
| PROCEPT BioRobotics Corporation | 404.71 Million USD | 19.402% |
| IRadimed Corporation | 92.15 Million USD | -253.958% |
| Tivic Health Systems, Inc. | 5.25 Million USD | -6108.489% |
| INVO Bioscience, Inc. | 20.88 Million USD | -1461.649% |
| Telesis Bio, Inc. | 70.41 Million USD | -363.271% |
| Viemed Healthcare, Inc. | 154.1 Million USD | -111.673% |
| Varex Imaging Corporation | 1.24 Billion USD | 73.896% |
| Quipt Home Medical Corp. | 247.4 Million USD | -31.845% |
| Inspira Technologies Oxy B.H.N. Ltd. | 9.31 Million USD | -3403.695% |
| Pulmonx Corporation | 178.95 Million USD | -82.281% |
| Dynatronics Corporation | 25.94 Million USD | -1157.467% |
| Modular Medical, Inc. | 13.8 Million USD | -2262.526% |
| ReShape Lifesciences Inc. | 10.72 Million USD | -2940.869% |
| Semler Scientific, Inc. | 78.06 Million USD | -317.849% |
| InMode Ltd. | 863.28 Million USD | 62.215% |
| Bruker Corporation | 4.24 Billion USD | 92.325% |
| Cytosorbents Corporation | 53.26 Million USD | -512.449% |
| DexCom, Inc. | 6.26 Billion USD | 94.793% |
| Align Technology, Inc. | 6.08 Billion USD | 94.638% |
| Viveve Medical, Inc. | 25.91 Million USD | -1158.804% |
| ZimVie Inc. | 1.2 Billion USD | 72.938% |
| Movano Inc. | 9.42 Million USD | -3362.414% |
| Cytek Biosciences, Inc. | 497.66 Million USD | 34.456% |
| Nexalin Technology, Inc. | 3.63 Million USD | -8881.32% |
| DIH Holdings US, Inc. Class A Common Stock | 58.66 Million USD | -456.066% |
| Tandem Diabetes Care, Inc. | 952.65 Million USD | 65.76% |
| Profound Medical Corp. | 43.68 Million USD | -646.673% |
| Insulet Corporation | 2.58 Billion USD | 87.397% |
| enVVeno Medical Corporation | 48.63 Million USD | -570.698% |
| Surmodics, Inc. | 185.73 Million USD | -75.625% |
| iCAD, Inc. | 41.41 Million USD | -687.566% |
| Nuwellis, Inc. | 9.77 Million USD | -3238.731% |
| Biotricity, Inc. | 5.94 Million USD | -5389.056% |
| iRhythm Technologies, Inc. | 433.14 Million USD | 24.692% |
| Aethlon Medical, Inc. | 8.24 Million USD | -3855.793% |
| InspireMD, Inc. | 47.64 Million USD | -584.663% |
| PAVmed Inc. | 33.11 Million USD | -884.915% |
| BIOLASE, Inc. | 35.1 Million USD | -829.301% |
| Beyond Air, Inc. | 56.96 Million USD | -472.662% |
| FONAR Corporation | 214.24 Million USD | -52.252% |
| AxoGen, Inc. | 196.82 Million USD | -65.726% |
| Vivani Medical, Inc. | 45.79 Million USD | -612.261% |
| Tactile Systems Technology, Inc. | 281.43 Million USD | -15.903% |
| Inari Medical, Inc. | 674.23 Million USD | 51.62% |
| UFP Technologies, Inc. | 404.13 Million USD | 19.286% |
| QT Imaging Holdings, Inc. | 23.39 Million USD | -1294.077% |
| Heart Test Laboratories, Inc. | 9.5 Million USD | -3332.496% |
| Tenon Medical, Inc. | 6.34 Million USD | -5040.961% |
| Autonomix Medical, Inc. Common Stock | 9.4 Million USD | -3367.567% |
| Co-Diagnostics, Inc. | 103.64 Million USD | -214.714% |
| AdaptHealth Corp. | 4.61 Billion USD | 92.939% |
| Sintx Technologies, Inc. | 15.36 Million USD | -2022.968% |
| NanoVibronix, Inc. | 6.67 Million USD | -4787.534% |
| Quanterix Corporation | 425.01 Million USD | 23.25% |
| Inspira Technologies Oxy B.H.N. Ltd. | 9.31 Million USD | -3403.695% |
| Sensus Healthcare, Inc. | 53.72 Million USD | -507.132% |
| Pacific Biosciences of California, Inc. | 1.74 Billion USD | 81.318% |
| TransMedics Group, Inc. | 706.04 Million USD | 53.8% |
| ReWalk Robotics Ltd. | 63.19 Million USD | -416.195% |
| NeuroMetrix, Inc. | 21.42 Million USD | -1422.532% |
| Hyperfine, Inc. | 94.19 Million USD | -246.282% |
| Establishment Labs Holdings Inc. | 268.64 Million USD | -21.424% |
| Biomerica, Inc. | 9.25 Million USD | -3424.897% |
| Bone Biologics Corporation | 3.73 Million USD | -8626.985% |
| AVITA Medical, Inc. | 144.33 Million USD | -125.99% |
| Bluejay Diagnostics, Inc. | 4.86 Million USD | -6600.05% |
| Silk Road Medical, Inc | 265.3 Million USD | -22.949% |